Knock out of specific maternal vitellogenins in zebrafish (Danio rerio) evokes vital changes in egg proteomic profiles that resemble the phenotype of poor quality eggs.
CRISPR/Cas9
Egg quality
Knock-out
LC-MS/MS
Proteomics
Vitellogenin
Zebrafish
Journal
BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258
Informations de publication
Date de publication:
28 Apr 2021
28 Apr 2021
Historique:
received:
15
12
2020
accepted:
30
03
2021
entrez:
29
4
2021
pubmed:
30
4
2021
medline:
15
5
2021
Statut:
epublish
Résumé
We previously reported the results of CRISPR/Cas9 knock-out (KO) of type-I and type-III vitellogenins (Vtgs) in zebrafish, which provided the first experimental evidence on essentiality and disparate functioning of Vtgs at different stages during early development. However, the specific contributions of different types of Vtg to major cellular processes remained to be investigated. The present study employed liquid chromatography and tandem mass spectrometry (LC-MS/MS) to meet this deficit. Proteomic profiles of zebrafish eggs lacking three type-I Vtgs simultaneously (vtg1-KO), or lacking only type III Vtg (vtg3-KO) were compared to those of wild type (Wt) eggs. Obtained spectra were searched against a zebrafish proteome database and identified proteins were quantified based on normalized spectral counts. The vtg-KO caused severe changes in the proteome of 1-cell stage zebrafish eggs. These changes were disclosed by molecular signatures that highly resembled the proteomic phenotype of poor quality zebrafish eggs reported in our prior studies. Proteomic profiles of vtg-KO eggs and perturbations in abundances of hundreds of proteins revealed unique, noncompensable contributions of multiple Vtgs to protein and in energy homeostasis. The lack of this contribution appears to have a significant impact on endoplasmic reticulum and mitochondrial functions, and thus embryonic development, even after zygotic genome activation. Increased endoplasmic reticulum stress, Redox/Detox activities, glycolysis/gluconeogenesis, enrichment in cellular proliferation and in human neurodegenerative disease related activities in both vtg1- and vtg3-KO eggs were found to be indicators of the aforementioned conditions. Distinctive increase in apoptosis and Parkinson disease pathways, as well as the decrease in lipid metabolism related activities in vtg3-KO eggs implies compelling roles of Vtg3, the least abundant form of Vtgs in vertebrate eggs, in mitochondrial activities. Several differentially abundant proteins representing the altered molecular mechanisms have been identified as strong candidate markers for studying the details of these mechanisms during early embryonic development in zebrafish and possibly other vertebrates. These findings indicate that the global egg proteome is subject to extensive modification depending on the presence or absence of specific Vtgs and that these modifications can have a major impact on developmental competence.
Sections du résumé
BACKGROUND
BACKGROUND
We previously reported the results of CRISPR/Cas9 knock-out (KO) of type-I and type-III vitellogenins (Vtgs) in zebrafish, which provided the first experimental evidence on essentiality and disparate functioning of Vtgs at different stages during early development. However, the specific contributions of different types of Vtg to major cellular processes remained to be investigated. The present study employed liquid chromatography and tandem mass spectrometry (LC-MS/MS) to meet this deficit. Proteomic profiles of zebrafish eggs lacking three type-I Vtgs simultaneously (vtg1-KO), or lacking only type III Vtg (vtg3-KO) were compared to those of wild type (Wt) eggs. Obtained spectra were searched against a zebrafish proteome database and identified proteins were quantified based on normalized spectral counts.
RESULTS
RESULTS
The vtg-KO caused severe changes in the proteome of 1-cell stage zebrafish eggs. These changes were disclosed by molecular signatures that highly resembled the proteomic phenotype of poor quality zebrafish eggs reported in our prior studies. Proteomic profiles of vtg-KO eggs and perturbations in abundances of hundreds of proteins revealed unique, noncompensable contributions of multiple Vtgs to protein and in energy homeostasis. The lack of this contribution appears to have a significant impact on endoplasmic reticulum and mitochondrial functions, and thus embryonic development, even after zygotic genome activation. Increased endoplasmic reticulum stress, Redox/Detox activities, glycolysis/gluconeogenesis, enrichment in cellular proliferation and in human neurodegenerative disease related activities in both vtg1- and vtg3-KO eggs were found to be indicators of the aforementioned conditions. Distinctive increase in apoptosis and Parkinson disease pathways, as well as the decrease in lipid metabolism related activities in vtg3-KO eggs implies compelling roles of Vtg3, the least abundant form of Vtgs in vertebrate eggs, in mitochondrial activities. Several differentially abundant proteins representing the altered molecular mechanisms have been identified as strong candidate markers for studying the details of these mechanisms during early embryonic development in zebrafish and possibly other vertebrates.
CONCLUSIONS
CONCLUSIONS
These findings indicate that the global egg proteome is subject to extensive modification depending on the presence or absence of specific Vtgs and that these modifications can have a major impact on developmental competence.
Identifiants
pubmed: 33910518
doi: 10.1186/s12864-021-07606-1
pii: 10.1186/s12864-021-07606-1
pmc: PMC8082894
doi:
Substances chimiques
Vitellogenins
0
Zebrafish Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
308Références
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Science. 2012 Aug 31;337(6098):1062-5
pubmed: 22936770
Fish Physiol Biochem. 2018 Dec;44(6):1509-1525
pubmed: 29882000
Biol Reprod. 1999 Jan;60(1):140-6
pubmed: 9858498
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Protein Sci. 2019 Nov;28(11):1947-1951
pubmed: 31441146
BMC Genomics. 2019 Apr 27;20(1):319
pubmed: 31029084
Trends Neurosci. 2008 Oct;31(10):521-8
pubmed: 18778858
Circ Res. 2019 Jan 4;124(1):142-149
pubmed: 30605407
Neural Regen Res. 2013 Jul 25;8(21):2003-14
pubmed: 25206509
BMC Evol Biol. 2009 Jan 05;9:2
pubmed: 19123940
Trends Biochem Sci. 2013 Aug;38(8):378-85
pubmed: 23768628
Cells. 2019 May 02;8(5):
pubmed: 31052568
Cell. 1984 Mar;36(3):729-40
pubmed: 6697394
Biochim Biophys Acta. 2012 Jul;1817(7):1002-11
pubmed: 22465854
J Proteome Res. 2014 Mar 7;13(3):1537-44
pubmed: 24460240
Nat Biotechnol. 2014 Mar;32(3):223-6
pubmed: 24727771
Front Cell Dev Biol. 2019 Nov 22;7:282
pubmed: 31824944
Dev Biol. 1976 Mar;49(1):1-10
pubmed: 943339
Bioessays. 1986 May;4(5):197-201
pubmed: 2431685
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Gen Comp Endocrinol. 2006 May 1;146(3):195-203
pubmed: 16430893
Anal Bioanal Chem. 2010 Jan;396(2):625-30
pubmed: 19789858
Fish Physiol Biochem. 2014 Apr;40(2):395-415
pubmed: 24005815
Organogenesis. 2008 Apr;4(2):68-75
pubmed: 19279717
PLoS One. 2007 Jan 24;2(1):e169
pubmed: 17245445
Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21146-51
pubmed: 21078990
Dev Cell. 2015 Nov 9;35(3):383-94
pubmed: 26555057
PLoS One. 2017 Nov 16;12(11):e0188084
pubmed: 29145436
J Biol Chem. 1987 Mar 25;262(9):4109-15
pubmed: 3031062
Biol Reprod. 2002 Aug;67(2):655-67
pubmed: 12135911
Biol Reprod. 1999 Sep;61(3):785-91
pubmed: 10456857
Biochim Biophys Acta. 2004 Jun 1;1699(1-2):35-44
pubmed: 15158710
Biol Reprod. 2010 Jul;83(1):52-62
pubmed: 20130269
Comp Biochem Physiol B Biochem Mol Biol. 2016 Apr-May;194-195:71-86
pubmed: 26643259
Comp Biochem Physiol A Mol Integr Physiol. 2004 Apr;137(4):739-48
pubmed: 15123182
J Reprod Fertil. 1988 Mar;82(2):769-75
pubmed: 3361510
Mol Cell Proteomics. 2012 Feb;11(2):M111.012682
pubmed: 21997732
Methods Mol Biol. 2009;563:123-40
pubmed: 19597783
Dev Biol. 2004 Jan 15;265(2):341-54
pubmed: 14732397
Obstet Gynecol Int. 2013;2013:183024
pubmed: 23766762
ACS Med Chem Lett. 2020 Mar 12;11(3):232-236
pubmed: 32184949
Dev Biol. 1999 Sep 1;213(1):18-32
pubmed: 10452844
Gene. 2005 Aug 15;356:91-100
pubmed: 15979250
Semin Cell Dev Biol. 2006 Apr;17(2):314-23
pubmed: 16574440
Biol Reprod. 2007 Jun;76(6):936-48
pubmed: 17314318
Mar Biotechnol (NY). 2009 Mar-Apr;11(2):169-87
pubmed: 18766402
Mol Reprod Dev. 2012 Jun;79(6):392-401
pubmed: 22467220
Int J Mol Sci. 2019 Jan 18;20(2):
pubmed: 30669355
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Mol Reprod Dev. 2019 Sep;86(9):1168-1188
pubmed: 31380595
Dev Biol. 1987 Oct;123(2):364-74
pubmed: 2443405
EMBO J. 2012 Mar 21;31(6):1336-49
pubmed: 22354038
Nucleic Acids Res. 2016 Jan 4;44(D1):D336-42
pubmed: 26578592
Proteomics. 2012 Jun;12(11):1879-82
pubmed: 22653788
Open Biol. 2017 Jul;7(7):
pubmed: 28679548
Cold Spring Harb Perspect Biol. 2013 Mar 01;5(3):a013169
pubmed: 23388626
Cell. 2014 Oct 9;159(2):242-51
pubmed: 25303523
BMC Dev Biol. 2006 Jan 13;6:1
pubmed: 16412219